Project test vehicle

The Japan Hydrogen and Fuel Cell Demonstration Project (JHFC), summarized in Fig. 4-13, is a program set up by the Ministry of Economy, Trade and Industry (METI) in March 2003. In this program, hydrogen refueling facilities with different types of fuel and production methods will be tested. Vehicles from five automakers are taking part in this project, including Toyota s FCHV and fuel cell bus. 

Einal report of the demonstration project testing of electric vehicles of the latest generation on Ruegen Island. Deutsche Automobilgesellschaft Braunschweig, 1997. 

Establishment of codes and standards (Millennium Project). In order to promote the establishment of codes and standards, the project focuses on R D on testing methodologies and data acquisition for PEFC vehicles and stationary PEFC systems. The goal is to promote international standardisation, fuel standard studies, establish performance and safety testing methods for public use, and reviewing of regulations. The 2003 allocation is 3.87 billion. 

The two fuel vehicles began operation late in the summer of 2007. Users maintain logs that document vehicle performance, and tests are ongoing to evaluate the operational experience and the refueling station. Other NREL evaluation projects involve transit buses powered by fuel cell hybrids in Oakland, California, Thousand Palms, California, and Hartford, Connecticut. 

The study described here has a very complex design for its exploratory approach. It combines four different extended release formulations, each tested under fasting and non-fasting conditions, and compares the results to the immediate release drug product as the reference formulation. The bilayer tablets combines an immediate release component and an extended release component in one vehicle. In this project a close cooperation between the galenics department and the clinical pharmacokinetic function was mandatory. The in vitro/in vivo correlation was done by means of the deconvolution which is an appropriate surrogate to describe the in vivo dissolution. 

The OQ consists of a series of tests based on LIMS FDS. When the pharmaceutical manufacturer is happy that the installation of LIMS has been satisfactorily completed, the project will move on to the stage where the functionality of the final system will be demonstrated. Operational Qualification (OQ) is the vehicle for providing documentary evidence of the demonstrated LIMS functionality for the independent parts of LIMS prior to full integration. There is again a need at the beginning of this phase to review any issues raised during the Design Review process and IQ. 

---